Cephalexin Dosing in Patients on Hemodialysis
Cephalexin (Keflex) dosing guidance in patients undergoing hemodialysis is not established in the U.S. prescribing information. [1][2]
FDA-Label Renal Dosing Table for Cephalexin
For renal impairment dosing, the label provides creatinine-clearance (CrCl)–based adjustments for patients not yet on dialysis. [1][2]
- CrCl 5 to 14 mL/min (not yet on dialysis): 250 mg PO every 24 hours. [1][2]
Hemodialysis-Specific Recommendation
The label states that there is insufficient information to make dose adjustment recommendations in patients on hemodialysis. [1][3]
Practical Dose-Adjustment Implications for Dialysis Patients
Because no validated hemodialysis regimen is provided in the label, cephalexin use in hemodialysis should be accompanied by careful clinical monitoring and individualized dosing based on patient response and adverse effects. [1][2]
Common Documentation Elements for Dialysis Prescribing
- Confirmation of dialysis modality (hemodialysis vs peritoneal dialysis) should be documented. [1]
- Current renal function metrics (e.g., CrCl estimates) should be documented. [1][2]
Sources for Alternative Institutional Guidance
When hemodialysis-specific dosing is needed, institutional antimicrobial stewardship resources or local dialysis antibiotic policies are commonly used because the product labeling does not provide a definitive hemodialysis dosing regimen. [1][3]
Safety Monitoring Considerations
Cephalexin should be used with caution in the setting of impaired renal function due to increased risk of toxic reactions. [1][2]
Final Recommended Regimen (Dialysis-Specific)
No fixed cephalexin dosing regimen is recommended for patients on hemodialysis in the U.S. product labeling because dose adjustment recommendations are not available. [1][3]